F-1286: Ex vivo-led drug discovery in glioblastoma

Gagg, H., Williams, S., Allen, R. orcid.org/0000-0003-2448-7987 et al. (7 more authors) (2022) F-1286: Ex vivo-led drug discovery in glioblastoma. In: Brain Tumor Research and Treatment. 6th Quadrennial Meeting of the World Federation of Neuro-oncology Societies (WFNOS 2022), 24-27 Mar 2022, Seoul, Korea. Korean Brain Tumor Society; Korea Society for Neuro-Oncology , s240.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 The Korean Brain Tumor Society, The Korean Society for Neuro-Oncology, and The Korean Society for Pediatric Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dates:
  • Published (online): 15 March 2022
  • Published: March 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Neuroscience (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 24 May 2023 16:55
Last Modified: 08 Jun 2023 09:44
Status: Published
Publisher: Korean Brain Tumor Society; Korea Society for Neuro-Oncology
Refereed: Yes
Identification Number: https://doi.org/10.14791/btrt.2022.10.f-1286
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)